EMERGENT BIOSOLUTIONS INC. COMMON STOCK

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

14 Aug 2023 09:47:06 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

11 Aug 2023 10:08:23 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

09 Aug 2023 09:47:06 By NetDania Notify

Emergent BioSolutions Reports Financial Results for Second Quarter 2023

08 Aug 2023 16:31:58 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position

08 Aug 2023 07:15:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

31 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

28 Jul 2023 10:48:07 By NetDania Notify

Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

20 Jul 2023 18:03:20 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

06 Jul 2023 09:46:07 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

05 Jul 2023 09:50:44 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

30 Jun 2023 11:04:33 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

29 Jun 2023 09:45:09 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

28 Jun 2023 15:05:38 By NetDania Notify

Emergent BioSolutions Announces CEO Transition

27 Jun 2023 07:55:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic

15 May 2023 07:58:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT

11 May 2023 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results For First Quarter 2023

09 May 2023 16:05:02 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023

19 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

29 Mar 2023 09:48:20 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022

27 Feb 2023 16:42:44 By Nasdaq GlobeNewswire